Your browser doesn't support javascript.
loading
Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis.
Augustin, Matthias; Mrowietz, Ulrich; Willsmann-Theis, Dagmar; Gerdes, Sascha; Fotiou, Konstantinos; Schuster, Christopher; Mert, Can; Holzkaemper, Thorsten; Behrens, Frank; Pinter, Andreas.
Afiliação
  • Augustin M; German Center for Health Services Research in Dermatology, Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Mrowietz U; Department of Dermatology, Psoriasis-Center, University Medical Center Schleswig-Holstein, Kiel, Campus Kiel, Germany.
  • Willsmann-Theis D; Clinic and Polyclinic for Dermatology and Allergology, University Hospital Bonn, Bonn, Germany.
  • Gerdes S; Department of Dermatology, Psoriasis-Center, University Medical Center Schleswig-Holstein, Kiel, Campus Kiel, Germany.
  • Fotiou K; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Schuster C; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Mert C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Holzkaemper T; HaaPACS GmbH, Schriesheim, Germany.
  • Behrens F; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Pinter A; Center for Innovative Diagnostics and Therapy Rheumatology/Immunology (CIRI) of the University of Frankfurt, Frankfurt am Main, Germany.
J Dtsch Dermatol Ges ; 22(2): 278-281, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38185772

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Doenças da Unha Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Doenças da Unha Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article